Cargando…

Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines

In an ongoing multinational trial, we obtained blood samples from 365 volunteers vaccinated with mRNA vaccines (Moderna, BioNTech), viral DNA-vectored vaccines (AstraZeneca, Sputnik-V, and Johnson and Johnson), or the attenuated virus vaccine from Sinopharm. After collecting reactogenicity data, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Adjobimey, Tomabu, Meyer, Julia, Sollberg, Leander, Bawolt, Michael, Berens, Christina, Kovačević, Peđa, Trudić, Anika, Parcina, Marijo, Hoerauf, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254618/
https://www.ncbi.nlm.nih.gov/pubmed/35799790
http://dx.doi.org/10.3389/fimmu.2022.917905
_version_ 1784740740257021952
author Adjobimey, Tomabu
Meyer, Julia
Sollberg, Leander
Bawolt, Michael
Berens, Christina
Kovačević, Peđa
Trudić, Anika
Parcina, Marijo
Hoerauf, Achim
author_facet Adjobimey, Tomabu
Meyer, Julia
Sollberg, Leander
Bawolt, Michael
Berens, Christina
Kovačević, Peđa
Trudić, Anika
Parcina, Marijo
Hoerauf, Achim
author_sort Adjobimey, Tomabu
collection PubMed
description In an ongoing multinational trial, we obtained blood samples from 365 volunteers vaccinated with mRNA vaccines (Moderna, BioNTech), viral DNA-vectored vaccines (AstraZeneca, Sputnik-V, and Johnson and Johnson), or the attenuated virus vaccine from Sinopharm. After collecting reactogenicity data, the expression of S-Protein binding IgG and IgA was analyzed using an automated sandwich ELISA system. Serum neutralizing potentials were then investigated using an ACE-2-RBD neutralizing assay. Moderna’s vaccine induced the highest amounts of SARS-CoV-2 specific neutralizing antibodies compared to the other groups. In contrast, Sinopharm and Johnson and Johnson’s vaccinees presented the lowest SARS-CoV-2-specific antibody titers. Interestingly, moderate to high negative correlations between age and virus-specific IgG expression were observed in the Johnson and Johnson (ρ =-0.3936) and Sinopharm (ρ =-0.6977) groups according to Spearman’s rank correlation analysis. A negative correlation was seen between age and IgA expression in the Sputnik-V group (ρ =-0.3917). The analysis of virus neutralization potentials in age categories demonstrated that no significant neutralization potential was observed in older vaccinees (61and 80 years old) in the Sputnik-V Johnson and Johnson and Sinopharm vaccinees’ groups. In contrast, neutralization potentials in sera of Moderna, BioNTech, and AstraZeneca vaccinees were statistically comparable in all age categories. Furthermore, while the AstraZeneca vaccine alone induced moderate IgG and IgA expression, the combination with Moderna or BioNTech mRNA vaccines induced significantly higher antibody levels than a double dose of AstraZeneca and similar IgG expression and neutralization potential compared to Moderna or BioNTech vaccines used alone. These results suggest that mRNA vaccines are the most immunogenic after two doses. DNA vectored vaccines from AstraZeneca and Sputnik-V presented lower but significant antibody expression and virus neutralizing properties after two doses. The lowest antibody and neutralization potential were observed in the Sinopharm or Johnson and Johnson vaccinees. Especially elderly over 60 presented no significant increase in neutralizing antibodies after vaccination. The data also indicate that heterologous vaccination strategies combining the AstraZeneca DNA vectored vaccines and mRNA vaccines are more effective in the induction of neutralizing antibodies compared to their homologous counterparts.
format Online
Article
Text
id pubmed-9254618
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92546182022-07-06 Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines Adjobimey, Tomabu Meyer, Julia Sollberg, Leander Bawolt, Michael Berens, Christina Kovačević, Peđa Trudić, Anika Parcina, Marijo Hoerauf, Achim Front Immunol Immunology In an ongoing multinational trial, we obtained blood samples from 365 volunteers vaccinated with mRNA vaccines (Moderna, BioNTech), viral DNA-vectored vaccines (AstraZeneca, Sputnik-V, and Johnson and Johnson), or the attenuated virus vaccine from Sinopharm. After collecting reactogenicity data, the expression of S-Protein binding IgG and IgA was analyzed using an automated sandwich ELISA system. Serum neutralizing potentials were then investigated using an ACE-2-RBD neutralizing assay. Moderna’s vaccine induced the highest amounts of SARS-CoV-2 specific neutralizing antibodies compared to the other groups. In contrast, Sinopharm and Johnson and Johnson’s vaccinees presented the lowest SARS-CoV-2-specific antibody titers. Interestingly, moderate to high negative correlations between age and virus-specific IgG expression were observed in the Johnson and Johnson (ρ =-0.3936) and Sinopharm (ρ =-0.6977) groups according to Spearman’s rank correlation analysis. A negative correlation was seen between age and IgA expression in the Sputnik-V group (ρ =-0.3917). The analysis of virus neutralization potentials in age categories demonstrated that no significant neutralization potential was observed in older vaccinees (61and 80 years old) in the Sputnik-V Johnson and Johnson and Sinopharm vaccinees’ groups. In contrast, neutralization potentials in sera of Moderna, BioNTech, and AstraZeneca vaccinees were statistically comparable in all age categories. Furthermore, while the AstraZeneca vaccine alone induced moderate IgG and IgA expression, the combination with Moderna or BioNTech mRNA vaccines induced significantly higher antibody levels than a double dose of AstraZeneca and similar IgG expression and neutralization potential compared to Moderna or BioNTech vaccines used alone. These results suggest that mRNA vaccines are the most immunogenic after two doses. DNA vectored vaccines from AstraZeneca and Sputnik-V presented lower but significant antibody expression and virus neutralizing properties after two doses. The lowest antibody and neutralization potential were observed in the Sinopharm or Johnson and Johnson vaccinees. Especially elderly over 60 presented no significant increase in neutralizing antibodies after vaccination. The data also indicate that heterologous vaccination strategies combining the AstraZeneca DNA vectored vaccines and mRNA vaccines are more effective in the induction of neutralizing antibodies compared to their homologous counterparts. Frontiers Media S.A. 2022-06-21 /pmc/articles/PMC9254618/ /pubmed/35799790 http://dx.doi.org/10.3389/fimmu.2022.917905 Text en Copyright © 2022 Adjobimey, Meyer, Sollberg, Bawolt, Berens, Kovačević, Trudić, Parcina and Hoerauf https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Adjobimey, Tomabu
Meyer, Julia
Sollberg, Leander
Bawolt, Michael
Berens, Christina
Kovačević, Peđa
Trudić, Anika
Parcina, Marijo
Hoerauf, Achim
Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
title Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
title_full Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
title_fullStr Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
title_full_unstemmed Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
title_short Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm’s COVID-19 Vaccines
title_sort comparison of iga, igg, and neutralizing antibody responses following immunization with moderna, biontech, astrazeneca, sputnik-v, johnson and johnson, and sinopharm’s covid-19 vaccines
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254618/
https://www.ncbi.nlm.nih.gov/pubmed/35799790
http://dx.doi.org/10.3389/fimmu.2022.917905
work_keys_str_mv AT adjobimeytomabu comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT meyerjulia comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT sollbergleander comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT bawoltmichael comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT berenschristina comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT kovacevicpeđa comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT trudicanika comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT parcinamarijo comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines
AT hoeraufachim comparisonofigaiggandneutralizingantibodyresponsesfollowingimmunizationwithmodernabiontechastrazenecasputnikvjohnsonandjohnsonandsinopharmscovid19vaccines